KarenJKragMD

PubMed

• 4 citations
  Baseline Screening MRI Uptake and Findings in Women with ≥ 20% Lifetime Risk of Breast Cancer.
  Alison Laws, Therese M. Mulvey, Nicole Jalbert, Sarah Dalton, Olga Kantor, Katherine A Harris, Karen Krag, Elizabeth P Walsh, Suzanne B. Coopey> ;Annals of Surgical Oncology. 2020 Jul 18
• 289 citations
  TBCRC009: A Multicenter Phase II Clinical Trial of Platinum Monotherapy With Biomarker Assessment in Metastatic Triple-Negative Breast Cancer
  Steven J. Isakoff, Erica L. Mayer, Lei He, Tiffany A. Traina, Lisa A. Carey, Karen Krag, Hope S. Rugo, Minetta C. Liu, Vered Stearns, Steven E. Come, Kirsten Timms, An...> ;Journal of Clinical Oncology. 2015 Apr 6
• 19 citations
  Attitudes of patients with metastatic breast cancer toward research biopsies
  Davinia Shien Seah, SM Scott, Julie Najita, Thomas H. Openshaw, Karen Krag, Elizabeth S. Frank, Jessica Sohl, Zsofia K. Stadler, M. Garrett, Stuart G. Silverman, Jeffr...> ;Annals of Oncology. 2013 Jul 1
• 44 citations
  Delta-6-desaturase activity and arachidonic acid synthesis are increased in human breast cancer tissue.
  Marilla C. Pender-Cudlip, Karen J. Krag, David Martini, Jeanne Yu, Anthony J. Guidi, Sandy S. Skinner, Yu Zhang, Xiying Qu, Chengwei He, Yi Xu, Steven Y. Qian, Jing X....> ;Cancer Science. 2013 Jun 1
• 7 citations
  Pathologic features and immunophenotype of estrogen receptor-positive breast cancers in BRCA1 mutation carriers.
  Jennifer Kaplan, Stuart J. Schnitt, Laura C. Collins, Yihong Wang, Judy Garber, Kelli Montgomery, Robert B. West, Karen Krag, Katharina Fetten, Anne Lincoln, Nadine Tung> ;The American Journal of Surgical Pathology. 2012 Oct 1
• 31 citations
  Prevalence and predictors of loss of wild type BRCA1 in estrogen receptor positive and negative BRCA1 -associated breast cancers
  Nadine Tung, Alexander Miron, Stuart J. Schnitt, Shiva Gautam, Katharina Fetten, Jennifer Kaplan, Yosuf Yassin, Ayodele Buraimoh, Ji Young Kim, Attila Marcell Szász, R...> ;Breast Cancer Research. 2010 Nov 16
• 73 citations
  Estrogen receptor positive breast cancers in BRCA1 mutation carriers: clinical risk factors and pathologic features
  Nadine Tung, Yihong Wang, Laura C. Collins, Jennifer Kaplan, Hailun Li, Rebecca Gelman, Amy Comander, Bridget Gallagher, Katharina Fetten, Karen Krag, Kathryn A. Stoec...> ;Breast Cancer Research. 2010 Feb 11
• 14 citations
  Phase II prospective study of paclitaxel and carboplatin in older patients with newly diagnosed Müllerian tumors.
  Ursula A. Matulonis, Karen J. Krag, Carolyn N. Krasner, T. Atkinson, Neil S. Horowitz, Hang Lee, Richard T. Penson> ;Gynecologic Oncology. 2009 Feb 1
• Sucrose dilution of frozen mouse embryos: interaction of glycerol and sucrose concentrations.
  Merry, D. A., Allen, R. L., Krag, K., Wright, R. W.> ;Theriogenology. 1983 Sep
• 27 citations
  Predictive factors for long-term survival in patients with advanced ovarian cancer
  K.J. Krag, George P. Canellos, C.T. Griffiths, Robert C. Knapp, Leroy M. Parker, William R. Welch, Mary M. Klatt, Janet Andersen> ;Gynecologic Oncology. 1989 Jul 1
• CT guided percutaneous calcaneoplasty: a case of metastatic intra-articular calcaneus fracture.
  Kamalian, S., Hirsch, A. E., Growney, M. L., Raskin, K. A., Yoo, A. J., Krag, K. J., Hirsch, J. A.> ;J Neurointerv Surg. 2009 Dec
• Join now to see all